QQ客服 官方微博 反馈留言

	COMBINATION OF AMLODIPINE WITH DIURETICS OR TELMISARTAN IN HIGH-RISK HYPERTENSIVE PATIENTS: THE CHINESE HYPERTENSION INTERVENTION EFFICACY STUDY (CHIEF)
	Wang, Wen; Zhang, Yuqing; Ma, Liyuan; Lu, Peipei; Meng, Xu; Li, Yanqi; Wang, Shu; Zhang, Xuezhong; Ma, Lihong; Zhou, Xianliang
	2018
卷号	36页码:E260-E260
关键词	Antihypertensive therapy calcium channel blockers diuretics angiotensin antagonists combination
ISSN号	0263-6352
DOI	10.1097/01.hjh.0000549063.40228.a1
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6349695
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, Wen,Zhang, Yuqing,Ma, Liyuan,et al. COMBINATION OF AMLODIPINE WITH DIURETICS OR TELMISARTAN IN HIGH-RISK HYPERTENSIVE PATIENTS: THE CHINESE HYPERTENSION INTERVENTION EFFICACY STUDY (CHIEF)[J],2018,36:E260-E260.
APA	Wang, Wen.,Zhang, Yuqing.,Ma, Liyuan.,Lu, Peipei.,Meng, Xu.,...&Hu, Aihua.(2018).COMBINATION OF AMLODIPINE WITH DIURETICS OR TELMISARTAN IN HIGH-RISK HYPERTENSIVE PATIENTS: THE CHINESE HYPERTENSION INTERVENTION EFFICACY STUDY (CHIEF).,36,E260-E260.
MLA	Wang, Wen,et al."COMBINATION OF AMLODIPINE WITH DIURETICS OR TELMISARTAN IN HIGH-RISK HYPERTENSIVE PATIENTS: THE CHINESE HYPERTENSION INTERVENTION EFFICACY STUDY (CHIEF)".36(2018):E260-E260.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。